| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
matrilin 3 | 0.644 | 0.385 | 1.4E-08 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
cullin 7 | 0.633 | 0.500 | 2.6E-21 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
parathyroid hormone 1 receptor | 0.544 | 0.731 | 0.57 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
FAM20C golgi associated secretory pathway kinase | 0.578 | 0.731 | 0.31 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
intraflagellar transport 122 | 0.560 | 0.846 | 2.4E-24 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
protein kinase cAMP-dependent type I regulatory subunit alpha | 0.401 | 0.846 | 1.00 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
dymeclin | 0.563 | 0.769 | 3.6E-13 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
acid phosphatase 5, tartrate resistant | 0.561 | 0.731 | 7.9E-02 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
pericentrin | 0.564 | 0.808 | 4.0E-58 |
|
phenotype | 0.400 | None | 0 | 0 | |||||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1 | 0.599 | 0.654 | 2.3E-06 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
discoidin domain receptor tyrosine kinase 2 | 0.541 | 0.769 | 0.55 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
receptor tyrosine kinase like orphan receptor 2 | 0.498 | 0.731 | 1.2E-04 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
natriuretic peptide receptor 2 | 0.573 | 0.615 | 4.2E-05 |
|
phenotype | 0.400 | None | 0 | 0 | |||||||||||
|
NIMA related kinase 1 | 0.575 | 0.769 | 1.9E-25 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
matrix metallopeptidase 13 | 0.452 | 0.923 | 7.9E-18 |
|
phenotype | 0.400 | None | 0 | 0 | |||||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
LIF receptor subunit alpha | 0.523 | 0.808 | 1.5E-13 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
WD repeat domain 35 | 0.525 | 0.692 | 1.0E-22 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
intraflagellar transport 80 | 0.575 | 0.692 | 1.4E-19 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
intraflagellar transport 140 | 0.572 | 0.692 | 9.9E-24 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
carbohydrate sulfotransferase 3 | 0.517 | 0.846 | 7.2E-03 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
eukaryotic translation initiation factor 2 alpha kinase 3 | 0.501 | 0.808 | 2.8E-03 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
thyroid hormone receptor interactor 11 | 0.595 | 0.654 | 1.7E-12 |
|
phenotype | 0.400 | None | 0 | 0 | |||||||||||
|
solute carrier family 39 member 13 | 0.666 | 0.538 | 2.5E-03 |
|
phenotype | 0.300 | None | 0 | 0 |